General Information of the Cell Line
Cell Line ID
CL000117
Cell Line Name
SF539
Synonyms
SF-539
SF-539 BT
SF.539
SF 539
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_1691
Tissue Information
Brain
Disease
Gliosarcoma (NCIt: C3796)
Gliosarcoma (ORDO: Orphanet_251576)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00844, Platelet-derived growth factor receptor beta
Compound ID Compound Name Compound Formula
CP0877991
7-Benzyl-N-(4-methoxyphenyl)-2,5-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine hydrochloride
   Show/Hide
C22H23ClN4O
 1
1
IC50 = 7.2 nM
   TI
   LI
   LO
   TS
CP0410331
7-benzyl-4-N-(4-methoxyphenyl)-4-N-methyl-5H-pyrrolo[3,2-d]pyrimidine-2,4-diamine
   Show/Hide
C21H21N5O
 1
1
IC50 = 8.1 nM
   TI
   LI
   LO
   TS
CP0906523
7-Benzyl-N-(4-methoxyphenyl)-N,2,5-trimethyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine hydrochloride
   Show/Hide
C23H25ClN4O
 1
1
IC50 = 10.3 nM
   TI
   LI
   LO
   TS
CP0906525
1-(7-Benzyl-2,5-dimethyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-6-methoxy-1,2,3,4-tetrahydroquinoline hydrochloride
   Show/Hide
C25H27ClN4O
 1
1
IC50 = 30.2 nM
   TI
   LI
   LO
   TS
CP0002211
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
   Show/Hide
C22H27FN4O2
 2
1
IC50 = 83.1 nM
   TI
   LI
   LO
   TS
2
IC50 = 12200 nM
   TI
   LI
   LO
   TS
CP0897293
1-(7-Benzyl-2-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-6-methoxy-1,2,3,4-tetrahydroquinoline hydrochloride
   Show/Hide
C24H25ClN4O
 1
1
IC50 = 90.3 nM
   TI
   LI
   LO
   TS
CP0091315
US9422297, AAG145-136
   Show/Hide
C17H13ClN4
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0402194
4-N-(3-bromophenyl)-7-[(2-chlorophenyl)methyl]pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C19H15BrClN5
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0402193
4-N-(3-bromophenyl)-7-[(3,4,5-trimethoxyphenyl)methyl]pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C22H22BrN5O3
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0008706
(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one
   Show/Hide
C15H14N2O
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0050064
US9422297, AAG145-135
   Show/Hide
C17H12ClFN4
 1
1
IC50 = 3600 nM
   TI
   LI
   LO
   TS
CP0016245
(3Z)-3-{[4-(dimethylamino)phenyl]methylidene}-2,3-dihydro-1H-indol-2-one
   Show/Hide
C17H16N2O
 2
1
IC50 = 3700 nM
   TI
   LI
   LO
   TS
2
IC50 = 3750 nM
   TI
   LI
   LO
   TS
CP0867392
N4-(4-Fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine
   Show/Hide
C17H13FN4
 1
1
IC50 = 5900 nM
   TI
   LI
   LO
   TS
CP0011624
AG1295
   Show/Hide
C16H14N2
 1
1
IC50 = 6200 nM
   TI
   LI
   LO
   TS
CP0093436
US9422297, AAG145-164
   Show/Hide
C17H12ClFN4
 1
1
IC50 = 6400 nM
   TI
   LI
   LO
   TS
CP0093435
US9422297, AAG145-161
   Show/Hide
C17H13FN4
 1
1
IC50 = 7100 nM
   TI
   LI
   LO
   TS
CP0160645
US9422297, AAG145-126
   Show/Hide
C20H20N4
 1
1
IC50 = 7800 nM
   TI
   LI
   LO
   TS
CP0096083
4-N-(3-bromophenyl)-6-[(2,5-dimethoxyphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C21H20BrN5O2
 1
1
IC50 = 8900 nM
   TI
   LI
   LO
   TS
CP0391385
4-N-(4-chlorophenyl)-6-(naphthalen-1-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C23H18ClN5
 1
1
IC50 = 8920 nM
   TI
   LI
   LO
   TS
CP0039638
2,4-diaminofuro[2,3-d]pyrimidine, 1a
   Show/Hide
C16H16N4O2
 1
1
IC50 = 12800 nM
   TI
   LI
   LO
   TS
CP0410666
4-N-(3-bromophenyl)-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C19H17BrN6
 1
1
IC50 = 13400 nM
   TI
   LI
   LO
   TS
CP0275218
4-N-(3-bromophenyl)-6-[(2,4-dichlorophenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C19H14BrCl2N5
 1
1
IC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0039635
2,4-diaminofuro[2,3-d]pyrimidine, 13
   Show/Hide
C19H24N4O2
 1
1
IC50 = 17400 nM
   TI
   LI
   LO
   TS
CP0416275
US9422297, AAG145-124
   Show/Hide
C20H20N4
 1
1
IC50 = 21700 nM
   TI
   LI
   LO
   TS
CP0864074
N4-(4-(Trifluoromethyl)phenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine
   Show/Hide
C18H13F3N4
 1
1
IC50 = 23100 nM
   TI
   LI
   LO
   TS
CP0400032
4-N-(4-chloro-2-fluorophenyl)-6-[(2,4-dichlorophenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C19H13Cl3FN5
 1
1
IC50 = 24600 nM
   TI
   LI
   LO
   TS
CP0372838
4-N-(3-bromophenyl)-7-[(2,4-dichlorophenyl)methyl]pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C19H14BrCl2N5
 1
1
IC50 = 34200 nM
   TI
   LI
   LO
   TS
CP0954268
N4-(4-Bromophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine
   Show/Hide
C17H13BrN4
 1
1
IC50 = 38900 nM
   TI
   LI
   LO
   TS
CP0454238
6-[(2,4-dichlorophenyl)methyl]-4-N-(2-propan-2-ylphenyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C22H21Cl2N5
 1
1
IC50 = 43000 nM
   TI
   LI
   LO
   TS
CP0093434
US9422297, AAG145-158
   Show/Hide
C17H14N4
 1
1
IC50 = 43100 nM
   TI
   LI
   LO
   TS
CP0395235
4-N-(4-chlorophenyl)-6-[(2,5-dimethoxyphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C21H20ClN5O2
 1
1
IC50 = 44300 nM
   TI
   LI
   LO
   TS
CP0167979
4-N-(3-bromophenyl)-6-[(2-methylphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C20H18BrN5
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0392884
4-N-(4-chloro-2-fluorophenyl)-6-[(2-methylphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
   Show/Hide
C20H17ClFN5
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0473414
5-chloro-4-N-(3-methoxyphenyl)-9H-pyrimido[4,5-b]indole-2,4-diamine
   Show/Hide
C17H14ClN5O
 1
1
IC50 = 50500 nM
   TI
   LI
   LO
   TS
CP0111386
5-naphthalen-1-ylsulfanyl-9H-pyrimido[4,5-b]indole-2,4-diamine
   Show/Hide
C20H15N5S
 1
1
IC50 = 58200 nM
   TI
   LI
   LO
   TS
CP0267274
5-(4-methoxyphenyl)sulfanyl-9H-pyrimido[4,5-b]indole-2,4-diamine
   Show/Hide
C17H15N5OS
 1
1
IC50 = 60500 nM
   TI
   LI
   LO
   TS
CP0431281
N-(4-anilino-5-chloro-9H-pyrimido[4,5-b]indol-2-yl)-2,2-dimethylpropanamide
   Show/Hide
C21H20ClN5O
 1
1
IC50 = 70600 nM
   TI
   LI
   LO
   TS
CP0250195
US9422297, AAG145-159
   Show/Hide
C18H16N4O
 1
1
IC50 = 75500 nM
   TI
   LI
   LO
   TS
CP0037987
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
   Show/Hide
C22H23N3O4
 1
1
IC50 = 83100 nM
   TI
   LI
   LO
   TS
CP0727218
5-[(Z/E)-2-(20-Methoxyphenyl)pent-1-en-1-yl]furo[2,3-d]-pyrimidine-2,4-diamine
   Show/Hide
C18H20N4O2
 1
1
IC50 = 88200 nM
   TI
   LI
   LO
   TS
CP0469395
N-[4-(3-bromo-4-fluoroanilino)-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]-2,2-dimethylpropanamide
   Show/Hide
C24H24BrFN6O
 1
1
IC50 = 89700 nM
   TI
   LI
   LO
   TS
CP0199922
5-naphthalen-2-ylsulfanyl-9H-pyrimido[4,5-b]indole-2,4-diamine
   Show/Hide
C20H15N5S
 1
1
IC50 = 90100 nM
   TI
   LI
   LO
   TS
CP0464065
7-benzyl-4-(6-methoxy-3,4-dihydro-2H-quinolin-1-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine
   Show/Hide
C23H23N5O
 1
1
IC50 > 200 nM
   TI
   LI
   LO
   TS
CP0910286
7-Benzyl-4-(5-methoxyindolin-1-yl)-2-methyl-5H-pyrrolo[3,2-d]pyrimidine hydrochloride
   Show/Hide
C23H23ClN4O
 1
1
IC50 > 200 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0003433
(Arylindolyl)maleimide deriv. 27
   Show/Hide
C21H16N4O2  1
1
LC50 = 42400 nM
   TI
   LI
   LO
   TS
CP0006369
6-[3-[4-[1-(5-cyanopentyl)indol-3-yl]-1-hydroxy-2,5-dioxopyrrol-3-yl]indol-1-yl]hexanenitrile
   Show/Hide
C32H31N5O3  1
1
LC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0015738
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
   Show/Hide
C24H36N4O6S2  1
1
GI50 = 3.6 nM
   TI
   LI
   LO
   TS
CP0062042
5-(2,5-Dihydroxy-benzylamino)-2-hydroxy-N-(2-pyridin-2-yl-ethyl)-benzamide
   Show/Hide
C21H21N3O4  1
1
GI50 = 29000 nM
   TI
   LI
   LO
   TS
CP0082019
(2R)-2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid
   Show/Hide
C22H21NO2S  1
1
GI50 = 790 nM
   TI
   LI
   LO
   TS
CP0085832
(1R,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
   Show/Hide
C24H36N4O6S2  1
1
GI50 = 3.6 nM
   TI
   LI
   LO
   TS
CP0086475
2-[(4-methoxyphenyl)-diphenylmethyl]sulfanylethanamine
   Show/Hide
C22H23NOS  1
1
GI50 = 250 nM
   TI
   LI
   LO
   TS
CP0184260
N-[2-(4-bromophenyl)ethyl]-5-[(2,5-dihydroxyphenyl)methylamino]-2-hydroxybenzamide
   Show/Hide
C22H21BrN2O4  1
1
GI50 = 15800 nM
   TI
   LI
   LO
   TS
CP0212776
5-(2,5-Dihydroxy-benzylamino)-2-hydroxy-N-phenethyl-benzamide
   Show/Hide
C22H22N2O4  1
1
GI50 = 17000 nM
   TI
   LI
   LO
   TS
CP0267543
5-(2,5-Dihydroxy-benzylamino)-N-hexyl-2-hydroxy-benzamide
   Show/Hide
C20H26N2O4  1
1
GI50 = 2300 nM
   TI
   LI
   LO
   TS
CP0270683
5-(2,5-Dihydroxy-benzylamino)-2-hydroxy-N-(3-phenyl-propyl)-benzamide
   Show/Hide
C23H24N2O4  1
1
GI50 = 16000 nM
   TI
   LI
   LO
   TS
CP0370065
5-(4-chlorophenyl)-2-(4-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazole
   Show/Hide
C17H12ClN3OS  1
1
LC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0451721
(1S,7R,10S,16E,21R)-7-benzyl-21-propan-2-yl-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
   Show/Hide
C26H34N4O6S2  1
1
GI50 = 3.3 nM
   TI
   LI
   LO
   TS
CP0465282
4-N-(4-methoxyphenyl)-4-N-methyl-9H-pyrimido[4,5-b]indole-2,4-diamine
   Show/Hide
C18H17N5O  1
1
GI50 = 24.2 nM
   TI
   LI
   LO
   TS
CP0517983
N-[4-[2-[(2S,3S,5S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]-1,3-dithian-2-yl]phenyl]-N'-hydroxyoctanediamide
   Show/Hide
C34H52N4O7S2Si  1
1
GI50 = 4570.88 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Brain)
Cell Line Name Organism Disease
TS603 Homo sapiens (Human) Anaplastic oligodendroglioma
H4 Homo sapiens (Human) Astrocytoma
1321N1 Homo sapiens (Human) Astrocytoma
SNB-19 Homo sapiens (Human) Astrocytoma
U-251MG Homo sapiens (Human) Astrocytoma
U-373MG ATCC Homo sapiens (Human) Astrocytoma
LN-308 Homo sapiens (Human) Astrocytoma
CCF-STTG1 Homo sapiens (Human) Astrocytoma
LN-319 Homo sapiens (Human) Astrocytoma
P2X7-1321N1 Homo sapiens (Human) Astrocytoma
MDA-MB-361 Homo sapiens (Human) Breast adenocarcinoma
JEG-3 Homo sapiens (Human) Gestational choriocarcinoma
D3 [Human glioblastoma] Homo sapiens (Human) Glioblastoma
LN-229 Homo sapiens (Human) Glioblastoma
LN-18 Homo sapiens (Human) Glioblastoma
A-172 Homo sapiens (Human) Glioblastoma
UC-11MG Homo sapiens (Human) Glioblastoma
T98G Homo sapiens (Human) Glioblastoma
LN229-V6R Homo sapiens (Human) Glioblastoma
MED1 Homo sapiens (Human) Medulloblastoma, non-WNT/non-SHH, group 4
Kelly Homo sapiens (Human) Neuroblastoma
PFSK-1 Homo sapiens (Human) Primitive neuroectodermal tumor
DU145 Homo sapiens (Human) Prostate carcinoma
DU145-TxR Homo sapiens (Human) Prostate carcinoma
GL261 Mus musculus (Mouse) Mouse glioblastoma
C6 Rattus norvegicus (Rat) Rat malignant glioma
C6-BU-1 Rattus norvegicus (Rat) Rat malignant glioma
RG2 Rattus norvegicus (Rat) Rat malignant glioma
ReNcell VM Homo sapiens (Human) -
hCMEC/D3 Homo sapiens (Human) -
BV-2 Mus musculus (Mouse) -
C17.2 Mus musculus (Mouse) -
ScGT1 Mus musculus (Mouse) -
bEnd.4 Mus musculus (Mouse) -
N39 Mus musculus (Mouse) -
GT1-7 Mus musculus (Mouse) -
N27-A Rattus norvegicus (Rat) -
RBE4 Rattus norvegicus (Rat) -